Philadelphia Pharmaceuticals Company (ASE:PHIL)
Jordan flag Jordan · Delayed Price · Currency is JOD
1.590
0.00 (0.00%)
At close: May 10, 2026

ASE:PHIL Ratios and Metrics

Millions JOD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
121211111010
Market Cap Growth
15.83%6.67%4.90%2.88%1.46%-4.20%
Enterprise Value
131212111111
Last Close Price
1.611.531.371.241.161.09
PE Ratio
11.6711.9413.6913.2914.8725.05
PS Ratio
1.341.311.281.281.241.56
PB Ratio
0.910.890.860.840.840.85
P/TBV Ratio
1.200.890.860.840.841.06
P/FCF Ratio
13.7810.367.3710.375.373.49
P/OCF Ratio
10.668.756.549.754.953.27
EV/Sales Ratio
1.401.351.361.361.281.66
EV/EBITDA Ratio
7.126.957.136.948.8312.45
EV/EBIT Ratio
8.258.048.538.459.7915.22
EV/FCF Ratio
14.4010.687.8011.075.543.72
Debt / Equity Ratio
0.170.130.150.120.150.12
Debt / EBITDA Ratio
1.300.991.190.901.501.65
Debt / FCF Ratio
2.641.521.301.440.940.49
Net Debt / Equity Ratio
0.040.000.030.010.03-0.02
Net Debt / EBITDA Ratio
0.31-0.040.200.060.27-0.24
Net Debt / FCF Ratio
0.62-0.060.220.090.17-0.07
Asset Turnover
0.520.540.540.530.550.44
Inventory Turnover
2.222.242.452.662.931.83
Quick Ratio
2.322.812.902.392.272.87
Current Ratio
3.173.723.673.082.733.48
Return on Equity (ROE)
7.96%7.57%6.37%6.42%5.72%3.48%
Return on Assets (ROA)
5.52%5.67%5.34%5.32%4.44%2.99%
Return on Invested Capital (ROIC)
9.24%9.06%8.42%8.38%7.22%5.10%
Return on Capital Employed (ROCE)
11.00%10.80%10.10%10.60%8.90%5.90%
Earnings Yield
8.57%8.38%7.30%7.53%6.73%3.99%
FCF Yield
7.26%9.65%13.57%9.64%18.62%28.63%
Dividend Yield
4.40%-5.12%5.63%5.19%5.51%
Payout Ratio
50.72%52.23%63.91%55.75%64.18%-
Total Shareholder Return
4.52%-5.12%5.63%5.19%5.51%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.